http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_191f9f901622232de240d4cd0276f4df
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | P. Leonard Leonard |
| name | John P. Leonard John P Leonard |
| given-name | John P John P. John |
| organization-name | Weill Cornell Medicine, New York, NY Weill Cornell Medicine, New York, NY, USA; 8Weill Medical College of Cornell University, New York, New York All authors: Weill Cornell Medicine and New York Presbyterian Hospital, New York NY. Division of Hematology and Oncology Department of Medicine Weill Cornell Medicine New York New York Division of Hematology/Oncology, Department of Medicine, and John P. Leonard, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY; Kathryn S. Kolibaba, Compass Oncology, Vancouver, WA; Kathryn S. Kolibaba and Nicholas J. DiBella, US Oncology Research, The Woodlands; Robert Collins, University of Texas Southwestern Medical Center, Dallas, TX; James A. Reeves, Florida Cancer Specialists, Fort Myers; Julio Hajdenberg, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; Anil Tulpule, Keck Medicine of University of Southern... From the New York University Cancer Institute, NYU Langone Medical Center, New York, NY; Weill Cornell Cancer Center, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY. Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York City, NY; Department of Medicine and Meyer Cancer Center Weill Cornell Medicine New York New York Department of Medicine, Weill Medical College of Cornell University, New York, NY; and; New York Presbyterian Hospital, New York, NY Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY Cornell University, New York, NY; Department of Medicine, Division of Hematology and Medical Oncology Weill Cornell Medicine New York New York From the Genetics Institute, Wyeth-Ayerst Research, Cambridge, MA. Weill Cornell Medical College, New York, New York Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY 1Division of Hematology and Oncology and Center for Lymphoma and MyelomaWeill Cornell Medical College, The New York-Presbyterian Hospital, USA From the Center for Lymphoma and Myeloma, Divisions of Hematology and Medical Oncology and Biostatistics and Epidemiology, and Departments of Medicine, Pathology, Laboratory Medicine, and Public Health, Weill Cornell Medical College; and New York Presbyterian Hospital, New York, NY. Weill Cornell Medicine and New York Presbyterian Hospital 1Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY Nancy L. Bartlett, MD, Washington University School of Medicine, St Louis, MO; Wyndham H. Wilson, MD, PhD, National Institutes of Health, Bethesda, MD; and John P. Leonard, MD, Weill Medical College of Cornell University, New York, NY Weill Cornell Medicine New York New York USA Department of Medicine, Division of Hematology and Oncology, Meyer Cancer Center, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY, USA; Division of Hematology and Medical Oncology, Weill Cornell Medical Center, New York, NY The Department of Hematology and Oncology, Weill Cornell Medical College, New York, New York (Leonard) 1Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York; From the University of Michigan Medical Center, Ann Arbor, MI; Christie Hospital, Manchester, UK; Rush-Presbyterian-St Luke's Medical Center, Chicago, IL; The New York Hospital-Cornell Medical Center, New York, NY; Stanford University Medical Center, Stanford, CA; Corixa Corporation, Seattle, WA; and Johns Hopkins School of Medicine, Baltimore, MD From the Center for Cancer Research and Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda; Clinical Pharmacology Program, SAIC-Frederick, Frederick, MD; North Shore University Hospital, Manhasset; New York Presbyterian Hospital, New York, NY; City of Hope National Cancer Center, Duarte, CA; University of Pittsburgh, Pittsburgh, PA; Mayo Clinic Scottsdale, Scottsdale, AZ; Peter MacCallum Cancer Centre and... Oncology Services, Weill Medical College of Cornell University, New York Presbyterian Hospital, NY, USA. 1Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York. John P. Leonard, Meyer Cancer Center, Weill Cornell Medical College and New York Presbyterian Hospital, New York; Myron Czuczman, Roswell Park Cancer Institute, Buffalo, NY; Sin-Ho Jung, Jeffrey Johnson, and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; Kristie A. Blum, Ohio State University Medical Center, Columbus, OH; Jeffrey K. Giguere, Greenville Community Clinical Oncology Program,... From the Lymphoid Malignancies Branch (R.S., D.W.H., J.D.P., J.Q.W., S.R., M.K., R.M.Y., A.L.S., D.J.H., W. Xiao, X.Y., Y.Y., H.Z., W. Xu, W.H.W., L.M.S.), the Biometric Research Program, Division of Cancer Diagnosis and Treatment (G.W.W.), and the Laboratory of Pathology, Center for Cancer Research (E.S.J., S.P.), National Cancer Institute, and the Office of Intramural Research, Center for Information Technology (C.A.J., X.L., B.Z., W.D.), National Institutes of Health, Bethesda, and the Cancer Research... Cornell University Medical College, New York, NY From the Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, and Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY; Immunomedics Inc, Morris Plains, NJ; and Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ Weill Cornell Medical Center, New York, NY; Ronald Levy, Andrew J. Gentles, Chih Long Liu, Robert Tibshirani, and Ash A. Alizadeh, Stanford University Medical Center, Palo Alto; Christos E. Emmanouilides and John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles; Lori A. Kunkel, Diane E. Ingolia, and Dan W. Denney Jr, Genitope, Fremont, CA; Kristen N. Ganjoo and Michael J. Robertson, Indiana University Medical Center, Indianapolis, IN; John P. Leonard, Weill Medical College of Cornell University, New York, NY; Julie M.... 2Hematology and Oncology Division, Medicine Department, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York. Division of Hematology and Medical Oncology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY Mazyar Shadman, Ajay K. Gopal, David G. Maloney, and Oliver W. Press, University of Washington and Fred Hutchinson Cancer Research Center; Hongli Li and Michael LeBlanc, SWOG Statistical Center, Seattle, WA; Lisa Rimsza, Mayo Clinic Arizona, Scottsdale; Catherine M. Spier, University of Arizona, Tucson, AZ; John P. Leonard, Weill Cornell Medical College, New York; Jonathan W. Friedberg, Wilmot Cancer Institute, University of Rochester, Rochester, NY; Mark S. Kaminski, University of Michigan Health System... Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Division of Hematology‐Oncology Weill‐Cornell Medical College New York New York Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine , New York, NY 10021 , USA Authors' Affiliation: Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, and New York Presbyterian Hospital, New York, New York Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology; and Department of Medicine, Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York, NY From Sharp Healthcare; University of California; Favrille Inc, San Diego; Medical Group of North County, Vista; Scripps Cancer Center, La Jolla; Tower Hematology/Oncology Medical Group, Los Angeles, CA; University of Florida, Jacksonville, FL; University of Virginia, Charlottesville, VA; Henry Ford Hospital, Detroit, MI; New York Hospital-Cornell Medical Center, New York; Our Lady of Mercy Medical Center, Bronx, NY; Oncology/Hematology Care Inc, Cincinnati, OH; and Fox Chase Cancer Center, Philadelphia, PA Weill Medical College of Cornell University New york NY USA Weill Cornell Medicine and Division of Hematology and Medical Oncology, Meyer Cancer Center, New York Presbyterian Hospital, New York, NY; and Hematology and Medical Oncology, Weill Cornell Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA. Department of Medicine Division of Hematology and Oncology Meyer Cancer Center Weill Cornell Medical College and New York‐Presbyterian Hospital New York NY USA Department of Hematology/Oncology Weill Cornell Medical College New York NY USA 12Department of Medicine, Weill Cornell Medical College, Manhattan, NY From Wyeth Research, Cambridge, MA, and Department of Hematopoiesis, Holland Laboratory, American Red Cross, Rockville, MD. Meyer Cancer Center, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY; Division of Hematology and Medical Oncology; Meyer Cancer Center, Department of Medicine, Weill Cornell Medicine and New York–Presbyterian Hospital, New York, NY Meyer Cancer Center Weill Medical College of Cornell University and New York‐Presbyterian Hospital New York NY USA 3Departments of Pediatrics and Medicine and Laboratory Medicine, Weill Cornell Medical College, New York, New York. Department of Hematology and Oncology, NewYork-Presbyterian Hospital/Weill Cornell Medical College, New York, NY, USA Department of Medicine Weill Medical College of Cornell University New York New York USA Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY From the Department of Preclinical Research and Development, Genetics Institute, Andover, MA; and the Hematopoiesis Department, Holland Laboratory, American Red Cross, Rockville, MD. New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA Meyer Cancer Center, Weill Cornell Medicine, New York, NY;; Department of Medicine, New York Presbyterian Hospital, New York, NY; Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital. Weill Cornell Medical College, New York, NY Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY, USA Department of Medicine Weill Cornell Medicine and New York Presbyterian Hospital New York NY USA Department of Hematology and Oncology, Weill Cornell Medical College, New York, NY From the James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester; Memorial-Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York, NY; University of Michigan Cancer Center, Ann Arbor, MI; Johns Hopkins School of Medicine, Baltimore, MD; Stanford University Medical Center, Stanford, CA; University of Nebraska Medical Center, Omaha, NE; Corixa Corporation, Seattle, WA Center for Lymphoma and Myeloma, and Division of Hematology and Medical Oncology, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY Weill Cornell Medicine, New York, New York 2Department of Medicine, Weill Cornell Medical College, New York, New York. Department of Immunology, Genetics Institute, Cambridge, MA 02081 1Department of Inflammation, Wyeth Research, Cambridge, MA 02140 3Weill Medical College of Cornell University, and Department Medicine, Weill Cornell Medical College, New York, NY; Weill Cornell Medical College, New York, NY; and Department of Medicine, Weill Cornell Medical College, New York, NY; From the Center for Lymphoma and Myeloma, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY; Mailman School of Public Health, Columbia University, New York, NY; University of Nebraska Medical Center, Omaha, NE; and the Dana-Farber Cancer Institute, Boston, MA. Department of Medicine, Weill Cornell Medicine, New York, NY. Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY; ‖Department of Medicine, Weill Medical College of Cornell University, New York, NY 10065; and Oliver W. Press, Fred Hutchinson Cancer Research Center, and the University of Washington; Hongli Li and Michael LeBlanc, Fred Hutchinson Cancer Research Center, Seattle, WA; Heiko Schöder, David J. Straus, Craig H. Moskowitz, and Ariela Noy, Memorial Sloan Kettering Cancer Center; John P. Leonard, Weill Cornell Medical College and New York Presbyterian Hospital, New York City; Paul M. Barr and Jonathan W. Friedberg, University of Rochester Medical Center, Rochester, NY; Lisa M. Rimsza, University of... 10Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY Weill Medical College of Cornell University New York New York Weill Department of Medicine, Division of Hematology and Medical Oncology, Meyer Cancer Center, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY Weill Cornell Medical College, New York, NY; Weill Cornell Medical College New York NY USA Weill Medical College of Cornell University, New York, NY Department of Medicine Weill Cornell Medicine New York New York USA Joan and Sanford I. Weill Department of Medicine,; Division of Hematology and Medical Oncology, and; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine and NewYork–Presbyterian Hospital, New York, NY Weill Cornell Medicine, New York, NY;; New York Presbyterian Hospital, New York, NY; 1Division of Hematology and Medical Oncology, Weill Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY Department of Medicine Weill Cornell Medical College New York New York USA 1Hematology and Oncology Division, Department of Medicine, Weill Cornell Medicine, New York, New York. Andrew M. Evens, Tufts University School of Medicine, Boston; Aimee Kroll-Desrosiers, University of Massachusetts Medical School, Worcester, MA; Ranjana Advani and Stavroula Otis, Stanford University Medical Center, Stanford, CA; Oliver W. Press and Linda M. Parker, Fred Hutchinson Cancer Research Center, Seattle, WA; Izidore S. Lossos, Liat Nadav Dagan, and Jose Sandoval, University of Miami School of Medicine, Miami, FL; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Francisco J.... Authors' Affiliations: 1Division of Hematology and Oncology, Department of Medicine, 2Division of Biostatistics and Epidemiology, Department of Public Health, 3Weill Cornell Cancer Center, and Departments of 4Pathology and 5Pharmacology, Weill Cornell Medical College, Cornell University, New York, New York; 6Section of Hematology/Oncology, Department of Medicine, The University of Chicago; 7Department of Pathology, Northwestern University, Chicago, Illinois; 8Institute for Research in Immunology and Cancer and Department of Pathology and Cell Biology, University of Montreal, Montreal, Quebec; 9Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; 10IBM Research, Rio de Janeiro, Brazil; and 11Department of Oncological Sciences, University of Turin, Turin, Italy; Authors' Affiliations: 1Division of Hematology and Oncology, Department of Medicine, 2Division of Biostatistics and Epidemiology, Department of Public Health, 3Weill Cornell Cancer Center, and Departments of 4Pathology and 5Pharmacology, Weill Cornell Medical College, Cornell University, New York, New York; 6Section of Hematology/Oncology, Department of Medicine, The University of Chicago; 7Department of Pathology, Northwestern University, Chicago, Illinois; 8Institute for Research in Immunology and Cancer and Department of Pathology and Cell Biology, University of Montreal, Montreal, Quebec; 9Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, British Columbia, Canada; 10IBM Research, Rio de Janeiro, Brazil; and 11Department of Oncological Sciences, University of Turin, Turin, Italy Cornell Weill Medical Center, New York, NY From the University of Iowa Hospitals and Clinics, Iowa City, IA; Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY; and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI. Department of Medicine, Weill Cornell Medical Center, New York, NY, USA; Weill Cornell Medicine New York NY USA Meyer Cancer Center, Division of Hematology and Medical Oncology, Weill Department of Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, New York 6Department of Medicine, Weill Cornell Medical College, New York, NY Hematology and Medical Oncology Weill Cornell Medicine New York NY USA Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and NewYork Presbyterian Hospital, New York, NY, USA; Department of Medicine, Weill Cornell Medicine, New York, New York, USA From the University of Rochester, James P. Wilmot Cancer Center, Rochester; Weill Medical College of Cornell University/New York Presbyterian Hospital; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Wisconsin, Madison, WI; H. Lee Moffitt Cancer Center, Tampa, FL; Indiana University Medical Center, Indianapolis, IN; University of California Los Angeles School of Medicine, Los Angeles; City of Hope National Medical Center, Duarte, CA; Oregon Health and Science University, Portland, OR;... Center of Excellence for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Department of Medicine Center for Lymphoma and Myeloma, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10021, USA. [email protected] Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA From the Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Division of Nuclear Medicine, and Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY; and Corixa Corporation, Seattle, WA Authors' Affiliations: 1Department of Pathology and Laboratory Medicine; 2Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York; and 3Oncology Drug Discovery, Bristol-Myers Squibb Research and Development, Princeton, New Jersey Department of Biological Sciences and Laboratory of Integrative Neuroscience, University of Illinois, Chicago, Illinois Department of Medicine, Weill Cornell Medicine, New York, New York, USA.; Department of Medicine, NewYork Presbyterian Hospital, New York, New York, USA. Weill Cornell Medical Center, New York, NY; and From the Roswell Park Cancer Institute, Buffalo, NY; Biogen Idec Inc, San Diego, CA; Mayo Clinic, Rochester, MN; University of Nebraska, Omaha, NE; M.D. Anderson Cancer Center, Houston, TX; University of California Los Angeles, Los Angeles, CA; Arizona Cancer Center, Tucson, AZ; Duke University, Durham, NC; Cornell Medical Center, New York, NY; Northwestern University, Chicago, IL; and University of Colorado Health Sciences Center, Aurora, CO Department of Medicine, Weill Cornell Medical College, New York, NY; and Weill Cornell Medicine, New York, NY, USA Meyer Cancer Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY; Preclinical Research and Development, Genetics Institute, Andover, MA 01810 WEILL CORNELL MEDICINE Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY From the Service des Maladies du Sang Centre Hospitalier Regional, Lille; Centre Hospitalier Lyon-Sud, Lyon, France; New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY; The University of Texas M. D. Anderson Cancer Center, Houston, TX; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Medical Research Council Toxicology Unit, Leicester University, Leicester, United Kingdom; Immunomedics, Inc, Morris Plains; and Garden State Cancer Center, Belleville, NJ. Divisions of Hematology/Oncology and Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York. 1Center for Lymphoma and Myeloma,; 2Division of Hematology-Oncology, Department of Medicine, New York Presbyterian Hospital, New York, New York, USA. Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York, United States Hematology/Oncology Weill Cornell Medical College New York NY USA John P. Leonard Department of Medicine, Weill Cornell Medicine, New York, NY; Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY; Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY; *Department of Inflammation, Wyeth Research, Cambridge, MA 02140; 39Weill Department of Medicine, Weill Medical College, Cornell University, New York, NY; Division of Hematology and Medical Oncology, From the Center for Lymphoma and Myeloma, Division of Hematology and Oncology, and Department of Pathology, Weill Medical College of Cornell University and New York Presbyterian Hospital; New York, NY; Immunomedics, Inc, Morris Plains; Center for Molecular Medicine and Immunology; Garden State Cancer Center; Belleville, NJ; and Amgen Inc, Thousand Oaks, CA. |
Incoming Links
Showing number of triples: 1 to 449 of 449.